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 2 
Abstract 21 
Rhinoviral infection is a common trigger of the excessive inflammation observed during 22 
exacerbations of asthma and chronic obstructive pulmonary disease. Rhinovirus (RV) 23 
recognition by pattern recognition receptors activates the MAPK pathways, common inducers 24 
of inflammatory gene production. A family of dual-specificity phosphatases (DUSPs) can 25 
regulate MAPK function, but their roles in rhinoviral infection are not known. We 26 
hypothesised that DUSPs would negatively regulate the inflammatory response to RV 27 
infection. Our results revealed that p38 and JNK MAPKs play key roles in the inflammatory 28 
response of epithelial cells to RV infection. Three DUSPs previously shown to have roles in 29 
innate immunity, 1, 4 and 10, were expressed in primary bronchial epithelial cells, one of 30 
which, DUSP10, was down regulated by RV infection. Small interfering-RNA knock down of 31 
DUSP10 identified a role for the protein in negatively regulating inflammatory cytokine 32 
production in response to IL-1 alone and in combination with RV, without any effect on RV 33 
replication. This study identifies DUSP10 as an important regulator of airway inflammation in 34 
respiratory viral infection.  35 
 36 
Importance  37 
Rhinoviruses are one of the causes of the common cold. In patients with asthma or chronic 38 
obstructive pulmonary disease, viral infections, including rhinovirus, are the commonest 39 
cause of exacerbations. Novel therapeutics to limit viral inflammation are clearly required. 40 
The work presented here identifies DUSP10 as an important protein involved in limiting the 41 
inflammatory response in the airway without affecting immune control of the virus. 42 
  43 
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 3 
Introduction 44 
Human rhinoviruses (RV) frequently trigger exacerbations of airway diseases, such as asthma 45 
and chronic obstructive pulmonary disease, where excessive inflammation causes worsening 46 
airway obstruction and increased symptoms. RV belong to the Picornaviridae family, with 47 
positive-sense single-stranded RNA packaged into icosahedral virions. There are over one 48 
hundred and fifty serotypes, classified either phylogenetically, into A, B and C, or based on 49 
the receptor the virus binds on the cell surface (1, 2). The major group, comprising most of 50 
group A and all of group B, bind intracellular adhesion molecule-1 (3), and the minor group, 51 
comprising the remainder of group A, bind low-density lipoprotein receptor or related 52 
proteins (4, 5). Culture methods for group C have been discovered relatively recently, so 53 
investigation into this group has been limited, however it is known to bind cadherin-related 54 
family member 3 (6, 7).  55 
 56 
RV infect airway epithelial cells, which express several pattern recognition receptors capable 57 
of recognising distinct parts of the virus (8). Toll-like receptor 3 (TLR3) and the RIG-like 58 
receptors (RLRs), bind double-stranded RNA replication intermediates, and TLR2 on the cell 59 
surface binds the rhinoviral capsid (9-12). It has been suggested that TLRs 7 and 8 may also 60 
contribute to the response to RV (13, 14), however, we and others have found airway 61 
epithelial cells unresponsive to TLR7/8 ligands (10, 15-17). Activation of pattern recognition 62 
receptors leads to the production and release of inflammatory cytokines through several 63 
pathways, including the NF-B, interferon regulatory factor (IRF), and mitogen-activated 64 
protein kinase (MAPK) pathways. The MAPK pathways, p38, JNK and ERK, consist of a three-65 
tier kinase cascade culminating in phosphorylation of the MAPK on two residues, tyrosine and 66 
threonine. The activated MAPKs translocate into the nucleus and activate a range of 67 
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 4 
transcription factors, including AP-1, ATF, CREB, c/EBP and NF-B. The p38 pathway can also 68 
be activated by binding and internalisation of RV (18-20). Previous work has shown the 69 
importance of p38 and ERK MAPK in inducing cytokine release in response to RV infection of 70 
airway epithelial cell lines (21-23). This inflammatory response to RV can be further 71 
potentiated by IL-1. IL-1 signals through similar pathways to the TLRs and is known to 72 
activate the MAPKs (24, 25). Furthermore, IL-1 is released from RV infected immune cells, 73 
such as monocytes and macrophages, and would therefore be present in the infected airway 74 
(11). Previous work by our group has shown the importance of IL-1 in the immune response 75 
to RV, RV infection induces the release of both IL-1 and IL-1 whilst blocking IL-1 signalling 76 
significantly inhibits proinflammatory cytokine release (26), furthermore the addition of IL-1 77 
enhances cytokine production from epithelial cells in response to RV infection (27). Thus, it is 78 
imperative that the MAPK pathways are regulated in order to stop over production of 79 
cytokines and excessive inflammation.  80 
 81 
Dual-specificity phosphatases (DUSPs) are a family of proteins capable of dephosphorylating 82 
two residues in one substrate simultaneously. A subgroup of DUSPs, MAPK phosphatases 83 
(MKPs), dephosphorylate the MAPK proteins directly. So far ten MKPs have been 84 
characterised, three of which have been shown to negatively regulate innate immune 85 
signalling: DUSP1 (MKP1), DUSP4 (MKP2), and DUSP10 (MKP5). Knock out mice which lack 86 
each of these proteins individually, produce higher levels of inflammatory cytokines in 87 
response to TLR4 activation, associated with increased p38 and/or JNK MAPK activation (28-88 
32). It should be noted that another group have shown a conflicting role for DUSP4, with 89 
knock out mice producing lower levels of cytokines in response to TLR4 signalling (33). Much 90 
of this work has explored the role of DUSPs in bacterial infection, and little is known about 91 
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 5 
the ability of DUSPs to regulate the response to viruses, particularly within epithelial cells. 92 
More recently, bone-marrow derived macrophages (BMDMs) and dendritic cells taken from 93 
DUSP10 knock out mice have been shown to exhibit increased release of inflammatory 94 
cytokines and anti-viral interferons (IFN) in response to influenza infection (34).   95 
 96 
We hypothesised that one or more DUSPs would play a critical role in regulating the 97 
inflammatory response to RV infection. We determined that the p38 and JNK pathways were 98 
responsible for a large proportion of the CXCL8 produced by primary bronchial epithelial cells 99 
(PBECs) in response to RV infection, while ERK did not play as great a role. DUSPs 1, 4 and 10 100 
were expressed by PBECs. Expression of DUSPs 1 and 4 was unaltered by RV infection or IL-101 
1 stimulation, however RV decreased expression of DUSP10. Small interfering RNA (siRNA) 102 
knock down of DUSP10 identified a role for the protein in regulating the response to IL-1 103 
alone and in combination with RV. These results identify DUSP10 as an important regulator 104 
of the inflammatory response in epithelial cells and therefore a potential future therapeutic 105 
target for RV induced acute exacerbations.  106 
 107 
Results 108 
The p38 and JNK pathways play important roles in cytokine production in response to RV. 109 
It is well documented that the MAPK pathways play roles in inducing cytokine release in 110 
response to a variety of stimulants. This has previously been demonstrated for p38 and ERK 111 
in response to RV infection, with inhibition of either decreasing the release of CXCL8, a 112 
neutrophil chemoattractant (21-23). However, these studies utilised airway epithelial cell 113 
lines, BEAS-2B and 16HBE14o-, and the roles of these pathways in the response of PBECs to 114 
RV is not well characterised. In addition, the role of JNK in the response to RV is unknown, 115 
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 6 
although it has been shown to be critical in inducing CXCL8 release in a human astroglioma 116 
cell line in response to poly(I:C), a synthetic TLR3 ligand (35).   117 
 118 
To explore the contribution of each MAPK pathway to cytokine production in response to viral 119 
infection, a panel of MAPK inhibitors were used. PBECs were pretreated with the inhibitors 120 
for 1 h prior to stimulation with synthetic double-stranded RNA viral mimic, poly(I:C), and 121 
inhibitors remained present throughout the 24 h stimulation. Production of the inflammatory 122 
cytokine CXCL8, a downstream target of NF-κB activation, was measured at both the RNA and 123 
protein secretion levels using qRT-PCR and ELISA. Poly(I:C) stimulation led to an upregulation 124 
of CXCL8 mRNA expression and protein release which was unaffected by inhibition of ERK 125 
with PD90859. Inhibition of p38 or JNK reduced CXCL8 levels, however this was only 126 
statistically significant at the protein level for SB203580 (Figure 1 A). A similar pattern was 127 
observed in response to infection with a major and minor group strain of rhinovirus, RV16 128 
and RV1B respectively. PBECs were treated with MAPK inhibitors for 1 h prior to infection 129 
with RV, the inhibitors were present for the 1 h RV infection, and remained present for the 130 
following 48 h. CXCL8 expression was measured at 48 h as peak cytokine release was observed 131 
at this time-point (data not shown). Infection of PBECs with RV induced an increase in CXCL8 132 
mRNA and protein secretion. CXCL8 levels were dramatically reduced by inhibition of p38 133 
with either SB203580 or SB202190, or JNK with SP600125, although the reduction was less 134 
clear at the mRNA level (Figure 1 B and C). Inhibition of ERK by PD90859 did not significantly 135 
affect CXCL8 expression or release in response to RV1B infection (Figure 1 B). These data 136 
suggest that p38 and JNK have important roles in inducing CXCL8 production in response to 137 
infection with major or minor strains of RV, while ERK plays a lesser role.  138 
 139 
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 7 
DUSPs are expressed by PBECs. We therefore went on to investigate the expression and roles 140 
of DUSPs, important regulators of the MAPK pathways. To the best of our knowledge, the 141 
expression of DUSPs in PBECs has not previously been characterised. We first determined the 142 
gene expression of DUSPs 1, 4 and 10 using RT-PCR. Each DUSP was expressed by PBECs, even 143 
in unstimulated cells (Figure 2). The regulation of this expression in response to poly(I:C) or 144 
IL-1 stimulation was examined over 24 h, however no clear changes were observed in the 145 
expression of any of the DUSPs examined using this method (Figure 2). 146 
 147 
In order to examine DUSPs 1, 4 and 10 mRNA expression in more detail, the more sensitive 148 
technique of qRT-PCR was utilised.  PBECs were infected with RV1B or RV16, or stimulated 149 
with IL-1, over 24 h and qRT-PCR used to measure expression of DUSPs 1, 4 and 10. As no 150 
change in DUSP expression was seen in response to 10 ng/ml IL-1 (Figure 2), the 151 
concentration was increased to 100 ng/ml. Stimulation with 100 ng/ml IL-1 did not alter 152 
expression of any of the DUSPs (Figure 3). Expression of DUSP1 and DUSP4 was unaltered by 153 
infection with RV1B (Figure 3 A and B). Infection with RV16 increased DUSP1 mRNA 154 
expression at 24 h, however this was variable and non-significant (Figure 3 A). Poly(I:C) 155 
stimulation was also found to increase DUSP1 mRNA expression, as found previously (36), but 156 
had no effect on expression of DUSPs 4 and 10 (data not shown). Infection with either strain 157 
of RV caused a similar regulation of DUSP10 expression, with an initial increase, followed by 158 
a consistent and significant downregulation at 8 h post-infection, before returning to baseline 159 
by 24 h (Figure 3 C).  160 
 161 
DUSP10 protein expression followed a similar pattern, with a slight increase at 2 h following 162 
RV1B infection, before declining to below baseline levels (Figure 4 A). RV16 infection had a 163 
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 8 
similar effect on DUSP10 protein levels, but was not statistically significant (Figure 4 B). As in 164 
the mRNA expression (Figure 3), IL-1 stimulation had no effect on DUSP10 protein 165 
expression (Figure 4 C).  166 
 167 
DUSP10 does not regulate the response to RV. Out of the proteins examined, DUSP10 was 168 
the only one found to be regulated by RV infection, thus it was taken forward for further 169 
investigation. siRNA was used to successfully knock down DUSP10 expression in PBECs, 170 
reducing DUSP10 mRNA and protein levels to approximately 20% of control levels (Figure 5 A 171 
and B). Control and DUSP10 knockdown cells were then infected with RV1B or RV16, or 172 
stimulated with poly(I:C), for 24 h and the release of inflammatory protein CXCL8 measured 173 
by ELISA. Release of CXCL8 was unaffected by DUSP10 knock down (Figure 5 C).  174 
 175 
As DUSP10 has previously been shown to regulate type-I IFN production in response to 176 
influenza (34), the level of IFN- mRNA was measured at 16 h post RV infection. Low levels of 177 
IFN- were detected by qRT-PCR in response to poly(I:C) or either strain of RV, and this was 178 
unaffected by DUSP10 knock down (Figure 5 D). DUSP10 knock down also had no effect on 179 
levels of release of the interferon stimulated gene, CCL5, in response to RV (Figure 5 E). In 180 
response to poly(I:C) stimulation, CCL5 levels were reduced by DUSP10 knock down. 181 
However, this may be due to cell death caused by DUSP10 knock down as observed by eye 182 
(data not shown). RV replication at 24 h was also unaffected by DUSP10 knock down, with RV 183 
RNA levels similar between control and DUSP10 siRNA treatments (Figure 5 F).  184 
 185 
DUSP10 regulates the response to IL-1. Whilst DUSP10 knock down did not affect the 186 
response of PBECs to RV, the response to IL-1 was altered. Stimulation of PBECs with a range 187 
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 9 
of IL-1 concentrations induced mRNA production and protein release of CXCL8 (Figure 6 A 188 
and B). CXCL8 mRNA and protein levels were significantly increased in cells with reduced 189 
DUSP10 levels (Figure 6 A and B). As p38 and JNK were shown to be important inducers of 190 
CXCL8 production, the effect of DUSP10 knockdown on IL-1–induced MAPK activation was 191 
investigated. Levels of phosphorylated, activated p38 and JNK in response to IL-1 were 192 
measured in cells treated with DUSP10 or control siRNA. IL-1 stimulation upregulated 193 
phosphorylation of both proteins, but the level of activation was unaffected by DUSP10 knock 194 
down (Figure 6 C).  195 
 196 
In order to gain a wider view of the role of DUSP10 in IL-1 signalling, an array was used to 197 
determine the effect of DUSP10 knock down on the release of a variety of cytokines. The 198 
chosen array contained antibodies specific for 36 proteins known to be upregulated in 199 
response to inflammation (R&D ARY005B). The levels of each protein released by cells from 200 
one donor treated with DUSP10 or control siRNA prior to 24 h of stimulation with IL-1 were 201 
determined. IL-1 stimulation increased release of several cytokines by PBECs, including 202 
CXCL1, CXCL10, G-CSF, GM-CSF, IL-6, CXCL8 and IL-1 itself, and decreased the release of 203 
CXCL12 (Figure 7). In keeping with previous data shown above, DUSP10 knock down 204 
potentiated the IL-1 induced release of CXCL1, CXCL8 and IL-1, with IL-1 levels increasing 205 
1.71 fold in comparison to cells treated with control siRNA (Figure 7). Intriguingly, DUSP10 206 
knock down decreased levels of CXCL10 release in response to IL-1. These data supported a 207 
role for DUSP10 in regulating the inflammatory response of airway epithelial cells.  208 
 209 
IL-1 is released by PBECs in response to RV infection. In order to determine whether the 210 
role of DUSP10 in the response to IL-1 would be of relevance in a RV infection, the release 211 
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 10 
of IL-1 in response to RV was quantified. PBECs released around 180 pg/ml IL-1 in response 212 
to 24 h infection with both RV1B and RV16 (Figure 8).  213 
 214 
DUSP10 regulates the response of PBECs to dual stimulation with RV and IL-1. IL-1 is an 215 
important early signalling molecule in the airway. It has previously been shown to potentiate 216 
the response of airway epithelial cells to RV infection, increasing the release of CXCL8 by the 217 
bronchial epithelial cell line BEAS-2B (27). We therefore investigated whether IL-1 would 218 
potentiate the response of PBECs to RV and determined the role of DUSP10 in this setting. 219 
Stimulation with IL-1 or infection with RV16 caused modest increases in CXCL8, whilst the 220 
addition of IL-1 to RV16 infected cells significantly augmented CXCL8 release. At the mRNA 221 
level only the higher dose of IL-1, 10 ng/ml, caused observable increases in CXCL8 production 222 
compared to RV16 alone (Figure 9 A). However, both concentrations caused incremental 223 
increases in CXCL8 release (Figure 9 B). This response was further potentiated by DUSP10 224 
knock down, with significantly higher CXCL8 at the mRNA and protein level in comparison 225 
with control siRNA treated cells. A similar pattern was seen in response to infection with the 226 
minor group virus RV1B (Figure 9 C). To ensure that the increased CXCL8 in dual-stimulation 227 
was not due to an effect of IL-1 on viral replication, the amount of intracellular viral RNA 228 
levels were quantified by qRT-PCR. No significant effects were observed between RV16 alone 229 
and in combination with IL-1 (data not shown).  230 
 231 
In addition to the major and minor classification of rhinoviruses, they are grouped 232 
phylogenetically, into A, B and C. Both RV1B and RV16 belong to group A. Therefore, a third 233 
serotype, RV14, a major group rhinovirus belonging to group B was examined. In accordance 234 
with previous results, infection of PBECs with RV14 led to a small increase in CXCL8 release 235 
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 11 
which was unaffected by DUSP10 knock down. When RV14 infection was combined with IL-236 
1 stimulation, CXCL8 release was increased, and further potentiated by DUSP10 knock down 237 
(Figure 9 D). These data demonstrate a role for DUSP10 in negatively regulating the response 238 
of PBECs to RV when in combination with IL-1.  239 
 240 
DUSP10 has a similar role in PBECs isolated from COPD patients. In order to ensure that the 241 
role of DUSP10 is clinically relevant, its role in PBECs isolated from COPD patients was 242 
investigated. Infection of COPD PBECs with RV1B caused a similar pattern of change in 243 
expression of DUSP10 mRNA and protein as was seen in normal PBECs, with an initial increase, 244 
followed by a downregulation by 8 h (Figure 10). RV16 infection also had a similar effect on 245 
DUSP10 mRNA expression as was seen in normal PBECs, but this was not observed at the 246 
protein level. In keeping with normal PBECs, IL-1 stimulation did not affect expression of 247 
DUSP10 at either the mRNA or protein level. Furthermore, siRNA knock down of DUSP10 in 248 
COPD PBECs increased release of CXCL8 in response to a combination of RV16 and IL-1 249 
stimulation, as seen in normal PBECs.  250 
  251 
Discussion  252 
Rhinoviral infection causes exacerbations of underlying airway disease through excessive 253 
inflammatory responses. The MAPKs are known to be activated by rhinoviral infection (18-254 
21, 37), however the roles of each pathway in the inflammatory response of primary cells to 255 
RV have not been well characterised. Previous studies have found that inhibition of ERK or 256 
p38 reduces production of inflammatory cytokines in response to RV (21-23). In accordance 257 
with this, inhibition of the p38 or JNK MAPKs led to a decrease in inflammatory cytokine 258 
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production, however, ERK was found to have a lesser role, demonstrating differences 259 
between previously studied cell lines (BEAS-2B and 16HBE14o-) and primary cells. Although 260 
small molecule inhibitors may have off-target effects (38), the results strongly indicate that 261 
p38 and JNK are important inducers of inflammation in RV infection.  262 
 263 
Three members of the DUSP family, DUSPs 1, 4 and 10, have been shown to negatively 264 
regulate MAPK pathways in innate immune signalling, although their role in RV infection has 265 
not yet been studied. All three DUSPs were constitutively expressed by PBECs. DUSPs 1 and 4 266 
have previously been characterised as early response genes, with no constitutive expression 267 
of DUSP1 in primary human airway smooth muscle cells, or DUSP4 in mouse BMDMs or 268 
embryonic fibroblasts (33, 39, 40). In contrast, DUSP10 is constitutively present in HeLa cells 269 
and murine BMDMs, and upregulated by innate immune stimuli (34, 41). The expression of 270 
DUSPs 1 and 4 at baseline may be a specific characteristic of bronchial epithelial cells, as 271 
opposed to macrophages or fibroblasts. Differentiation of PBECs in air-liquid interface 272 
cultures has been shown to alter expression of cellular proteins, however previous gene 273 
expression arrays have not shown differences in DUSP1, 4, or 10 expression between 274 
submerged and differentiated cultures (42). 275 
 276 
Infection with either strain of RV caused a decrease in DUSP10 expression, at the mRNA and 277 
protein level, which was not seen in response to IL-1. In 2008, Proud et al. performed a gene 278 
expression array of nasal scrapings after experimental RV16 infection. DUSP10 mRNA 279 
expression was unchanged at 8 and 48 h post-infection (43). However, as the downregulation 280 
observed in our study was transient, changes in DUSP10 expression may have occurred 281 
outside of the two time points investigated in the Proud study. This downregulation of 282 
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DUSP10 may be a host or viral triggered response. In support of a host-mediated response, 283 
previous work has shown DUSPs 1 and 6 are regulated by proteasomal degradation in cells 284 
treated with growth factors or carcinogens (44, 45). However, many viruses target host 285 
proteins for degradation, either utilising host ubiquitin ligases or expressing their own (46, 286 
47). Rhinovirus also encodes its own proteinases 2A and 3C, which have been found to 287 
degrade components of the IFN signalling pathway (48), and of relevance the non-structural-288 
1 protein of human immunodeficiency virus has been shown to target DUSP1 for upregulation 289 
in order to limit the inflammatory response (49). The extent to which regulation of DUSP10 290 
in this context may be a pathogen-driven manipulation of the host immune system remains 291 
to be determined. 292 
 293 
In this study, DUSP10 expression was successfully knocked down using siRNA, allowing 294 
investigation into the role of this protein in RV infection of PBECs. Reduced DUSP10 levels did 295 
not affect RV replication, or IFN- production in response to RV or poly(I:C). This contrasts 296 
with the study by James et al. where influenza replication was decreased in DUSP10 knock 297 
out mice due to increased IFN levels (34). This implies specific roles for DUSP10 in individual 298 
pathogenic infections, potentially consequent upon differential TLR signalling by each virus 299 
(50). Interestingly, DUSP10 knock out BMDMs produced increased mRNA and secreted 300 
protein levels of IFN- in response to poly(I:C) (34). Thus, DUSP10 roles may be species and/or 301 
cell-type specific, emphasising the need for studies such as ours examining their role in 302 
primary human airway epithelial cells.  303 
 304 
Knock down of DUSP10 did not affect cytokine release in response to RV infection or poly(I:C) 305 
stimulation. However, in response to IL-1, DUSP10 knock down consistently caused an 306 
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increase in CXCL8 production. In order to gain a wider view of the role of DUSP10 a cytokine 307 
array was utilised.  Although this technique is semi-quantitative and includes samples from 308 
only one donor, it gives an indication of the points at which DUSP10 may be acting. 309 
Interestingly, DUSP10 knock down increased release of neutrophil chemoattractants CXCL8 310 
and CXCL1, and decreased release of CXCL10, a Th1 cell chemoattractant. The MAPK 311 
pathways have previously been shown to downregulate CXCL10 production in response to 312 
RV16 through negatively regulating IRF1 activity (51). However, p38 and JNK MAPK activation 313 
levels were unchanged by DUSP10 knock down, suggesting a potential novel target of 314 
DUSP10. Expression of IL-1 itself was also increased in DUSP10 knock down, which could 315 
point towards a role for DUSP10 in inflammasome regulation. Rhinoviral infection of PBECs is 316 
known to activate the NLRP3 and NLRC5 inflammasomes leading to IL-1 release (26, 52). 317 
More recently, RV infection has been found to increase caspase 1 expression to a greater 318 
extent in asthmatic PBECs than normal cells, and in a house dust mite murine model of asthma 319 
exacerbations, caspase 1 knock out mice had reduced Th2 responses to poly(I:C) (53). Thus, a 320 
potential role of DUSP10 in regulating the inflammasome has significant implications for 321 
asthma.  322 
 323 
IL-1 is an important inflammatory molecule shown to have roles in asthma and COPD (54, 324 
55) and IL-1 knock out mice have reduced neutrophilic and Th2 responses in a murine 325 
asthma model (56). Blocking IL-1 signalling in PBECs decreases the release of inflammatory 326 
mediators in response to RV infection (26). Previous work by our group and others has found 327 
a key role for IL-1 in cooperative signalling between monocytes/macrophages and epithelial 328 
cells. In vitro co-culture models have demonstrated that addition of monocytes to epithelial 329 
cells can exacerbate the inflammatory response to lipopolysaccharide, unless IL-1 signalling 330 
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is blocked with blocking antibodies or IL-1 receptor antagonist (IL-1Ra) (57-60). Monocytes 331 
have been shown to release IL-1 in response to RV infection (11), and cooperative signalling 332 
has also been demonstrated in the context of RV infection: addition of primary monocytes to 333 
BEAS-2B cells or PBECs increases the production of inflammatory cytokines, CXCL8, CCL2, and 334 
CXCL10, in response to RV (27, 61), and IL-1Ra inhibited this increased cytokine generation 335 
(27). In accordance with this, PBECs were found to release IL-1 in response to RV infection. 336 
Co-stimulating PBECs with RV and IL-1 was found to dramatically potentiate the response to 337 
RV alone. The response was further increased by loss of DUSP10. This was true for three 338 
serotypes of rhinovirus, including; a major group A, RV16, a minor group A, RV1B, and a major 339 
group B, RV14. This suggests that DUSP10 would have a role in the response to rhinoviral 340 
infection in the airway; RV inducing IL-1 release by monocytes, which stimulates epithelial 341 
cells to release cytokines, regulated by DUSP10. This anti-inflammatory role for DUSP10 was 342 
also observed in two independent COPD donors, with increased CXCL8 release in response to 343 
RV and IL-1 co-stimulation when DUSP10 was knocked down. COPD and asthma patients 344 
have been shown to have increased baseline levels of IL-1 (54, 62, 63), thus DUSP10 may 345 
have an increased role in a disease setting. However, this remains to be investigated as it was 346 
not possible to directly compare PBECs from healthy and COPD donors in this study, due to 347 
differences in isolation techniques. Therefore, any additional role of DUSP10 in inflammatory 348 
airway diseases remains to be investigated.  349 
 350 
These data demonstrate a novel role for DUSP10 in negatively regulating the inflammatory 351 
response of epithelial cells to IL-1 alone and in combination with RV. This suggests DUSP10 352 
has an important role in regulating inflammation of the airway and identifies it as a potential 353 
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 16 
future therapeutic target for exacerbations of asthma and chronic obstructive pulmonary 354 
disease.  355 
 356 
Materials and Methods 357 
Cells and Viruses. Primary human bronchial epithelial cells (PBECs) isolated from healthy 358 
humans were purchased from Promocell (Heidelberg, Germany) and PBECs isolated from 359 
patients with COPD were purchased from Lonza (Basel, Switzerland). Cells were maintained 360 
as previously described (27), and all experiments were carried out on at least three 361 
independent PBEC donors.  362 
 363 
Human rhinovirus serotypes 1B and 16 were propagated in HeLa Ohio cells (American Type 364 
Culture Collection) in DMEM (Gibco), supplemented with 2% FCS (Gibco), 2% hepes (Gibco), 365 
1% bicarbonate (Gibco) and penicillin-streptomycin (Invitrogen) as previously described (27). 366 
Human rhinovirus serotype 14 was a kind gift from MedImmune Ltd, Cambridge, UK. Viral 367 
titres were determined by TCID50 in HeLa Ohio cells.  368 
 369 
Inhibitor Treatment. Prior to cell stimulation or infection, cells were treated with the 370 
indicated concentration of MAPK inhibitor (Tocris), diluted in DMSO, for one hour. Inhibitors 371 
remained present throughout the experiment. 372 
 373 
siRNA Knock Down. PBECs were grown in 12 well plates until 80% confluent. Lipofectamine 374 
2000 (Invitrogen) and DUSP10 siRNA (Santa Cruz, sc-61048) or control siRNA (Dharmacon, D-375 
001810-02-05) were diluted to the indicated concentrations in Opti-Mem (Gibco) and 376 
equilibrated at room temperature for 5 minutes before both solutions were combined and 377 
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further equilibrated for 20 minutes. PBECs were washed in PBS and media replaced with fresh 378 
supplement-free airway epithelial cell basal media and siRNA mixtures were applied 379 
dropwise. Cells were incubated at 37oC, 5% CO2 for four hours before media was replaced 380 
with airway epithelial cell basal media, supplemented with penicillin-streptomycin and the 381 
airway epithelial cell supplement pack excepting bovine pituitary extract (recovery media). 382 
Cells were incubated at 37oC, 5% CO2 for 48 h prior to stimulation or infection. 383 
 384 
RV Infection of PBECs. PBECs were seeded in 12 well plates and grown to 80-90% confluency. 385 
Media was replaced with supplement-free airway epithelial cell basal medium and incubated 386 
at 37oC, 5% CO2 overnight. Cells were incubated with the indicated MOI of RV for one hour at 387 
37oC, 5% CO2 with agitation. MOIs were selected, based on preliminary concentration-388 
response optimisation experiments, to provide equivalent inflammatory cytokine release, 389 
and intracellular RV RNA copies (see also Figure 5C, D, F). Virus was removed and replaced 390 
with recovery media and cells were incubated at 37oC, 5% CO2 for the indicated time point. 391 
Cell free supernatants or cell lysates were harvested and stored at -80oC.  392 
 393 
IL-1 or Poly(I:C) Stimulation of PBECs. PBECs were seeded in 12 well plates and grown to 394 
80-90% confluency. Media was replaced with supplement-free airway epithelial cell basal 395 
medium and incubated at 37oC, 5% CO2 overnight. Media was replaced with recovery media 396 
containing the indicated concentration of IL-1 (Peprotech) or low molecular weight poly(I:C) 397 
(Invivogen). Cells were incubated at 37oC, 5% CO2 for the indicated time point. Cell free 398 
supernatants or cell lysates were harvested and stored at -80oC.  399 
 400 
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Co-treatment of PBECs with RV and IL-1. PBECs were infected with RV as described above. 401 
After removal of the virus, media was replaced with recovery media containing the indicated 402 
concentration of IL-1 (Peprotech). Cells were incubated at 37oC, 5% CO2 for the indicated 403 
time point. Cell free supernatants or cell lysates were harvested and stored at -80oC. 404 
 405 
PCR. RNA was extracted using Tri reagent (Sigma-Aldrich) according to the manufacturer’s 406 
instructions and contaminating DNA removed using a DNase treatment kit (Ambion). cDNA 407 
was generated from 1 g RNA using high-capacity cDNA reverse transcriptase kit (Applied 408 
Biosystems). 409 
 410 
PCR was carried out using the GoTaq hot start polymerase kit (Promega) according to the 411 
manufacturer’s instructions using primers specific to DUSPs 1, 4, and 10, and GAPDH (Sigma-412 
Aldrich). DUSP1 (F: GTCGTGCAGCAAACAGTCGA, R: CGATTAGTCCTCATAAGGTA; (62)), DUSP4 413 
(F: TTCAACAGGCATCCATCCCT, R: TGGCTTTGGGAGGGAATGAT), DUSP10 (F: 414 
ATGACCAAATGCAGCAAG, R: GGAGCTGGAGGGAGTTGTCAC; (63)), GAPDH (F: 415 
GGTGAAGGTCGGTGTGAAC, R: CTCGCTCCTGGAAGATGGTG).  416 
 417 
Quantitative PCR was carried out using primers and probes from Sigma-Aldrich for RV 418 
(SY150600935-024, SY150600935-025, HA07878670-002) and IFN- (SY150506722-061, 419 
SY150504450-060, HA07784503-002) and primer-probe sets from Applied Biosystems for 420 
DUSP1 (Hs00610256_g1), DUSP4 (Hs01027785_m1), DUSP10 (Hs00200527_m1), CXCL8 421 
(Hs00174103_m1), and GAPDH (Hs02758991_g1). Reaction mixtures were made using 422 
Promega GoTaq Probe qPCR master mix or Eurogentec qPCR mastermix and run using an 423 
ABI7900 fast real-time PCR system (Applied Biosystems) (50oC for 2 minutes, 95oC for 10 424 
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minutes, then cycled 40 times through 95oC for 15 seconds, 60oC for 1 minute). CXCL8, IFN-, 425 
and RV were quantified against a standard curve of plasmids containing known copy numbers 426 
of target genes. CXCL8, IFN-, DUSP1, DUSP4, and DUSP10 expression was normalised to 427 
GAPDH.  428 
 429 
ELISA. Enzyme-linked immunosorbent assay (ELISA) was used to detect CXCL8 and CCL5 in 430 
cell-free supernatants using matched antibody pairs from R&D systems. Levels of CXCL8 and 431 
CCL5, above the minimum detection level (CXCL8: 78.125 pg/ml, CCL5: 156.25 pg/ml), were 432 
quantified against a standard curve from the same plate. 433 
 434 
Cytokine Array. The presence of 36 proteins in cell-free supernatants was determined using 435 
R&D systems human cytokine array (ARY005B) according to manufacturer’s instructions. 436 
 437 
Western Blot. PBECs were lysed in buffer containing 1% Triton-X and boiled for 5 minutes in 438 
SDS-PAGE buffer. Lysates were subjected to SDS-PAGE and proteins transferred to 439 
nitrocellulose membrane. Membranes were blotted with antibodies to DUSP10 (Abcam), 440 
phosphorylated p38 (Promega), phosphorylated JNK (Cell Signalling), and actin (Sigma-441 
Aldrich). Antibodies were detected using HRP-conjugated anti-rabbit secondary antibody 442 
(Dako). Densitometric analysis was performed using ImageJ software (Version 1.50i; NIH).  443 
 444 
Statistical Analysis. All data presented, excluding figure 6, are mean  SEM (where 445 
appropriate) of at least three independent experiments using PBECs from different donors. 446 
Data were analysed using the statistical test stated in the figure legend on log data, as data 447 
are lognormally distributed. In figures 1, 6 A, and 9 A, normalised data has been presented 448 
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due to variability between PBEC donors. For normalised data or Ct qRT-PCR data, statistical 449 
tests were performed on raw data or Ct values respectively. Significant differences are 450 
indicated by *  p 0.05, **  p 0.01, ***  p 0.001, and **** p  0.0001.  451 
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Figure Legends 678 
Figure 1: Inhibition of the p38 or JNK pathways reduces cytokine release in response to RV 679 
infection. PBECs were treated with media only, DMSO or MAPK inhibitors (20 μM): PD90859 680 
(ERK), SB203580 (p38), SB202190 (p38) and SP600125 (JNK), for one hour prior to stimulation 681 
with poly(I:C) (25 μg/ml) for 24 h, n = 3 (A), or infection with RV1B (MOI 3) (B) or RV16 (MOI 682 
4) (C) for 48 h, n=4 individual donors. Inhibitors remained present throughout the experiment. 683 
Supernatants and cell lysates were collected and levels of CXCL8 mRNA and release were 684 
measured by qRT-PCR and ELISA. Data shown are mean ± SEM, normalised to RV + DMSO 685 
treated cells. Significance versus RV + DMSO treated cells is indicated by * ≤ p 0.05, ** p ≤ 686 
0.01, as measured by one-way ANOVA, Dunnett’s post-test on log raw data. 687 
 688 
Figure 2: DUSPs 1, 4 and 10 are expressed in PBECs. PBECs were stimulated with poly(I:C) (25 689 
μg/ml) (P), IL-1β (10 ng/ml) (β) or left untreated (U) over 24 hours. mRNA was collected at the 690 
time points indicated and RT-PCR performed using primers for DUSPs 1, 4 and 10 and a GAPDH 691 
control. n=2 individual donors with a representative gel shown. 692 
 693 
Figure 3: DUSP10 expression is decreased by RV infection. PBECs were infected with RV1B 694 
(MOI 3), RV16 (MOI 4), or IL-1β (100 ng/ml) over 24 h and cell lysates collected at the indicated 695 
time points. DUSP1 (A), DUSP4 (B) and DUSP10 (C) expression was measured using qRT-PCR. 696 
Data shown are mean ± SEM, n=3 individual donors. Significance versus uninfected control (0 697 
h) is indicated by * p ≤ 0.05, as measured by one-way ANOVA, Dunnett's post-test on log ΔCt 698 
values.   699 
 700 
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Figure 4: DUSP10 protein expression is decreased by RV infection. PBECs were infected with 701 
RV1B (MOI 3) (A), RV16 (MOI 4) (B), or IL-1β (100 ng/ml) (C) over 24 h and cell lysates collected 702 
at the indicated time points. DUSP10 and actin expression was measured using western blot. 703 
Data shown are mean ± SEM of densitometry, n=3 individual donors, with representative blot 704 
below. Significance is indicated by * p ≤ 0.05, as measured by one-way ANOVA, Dunnett's 705 
post-test on log values. Please note, blots shown are segments of longer time courses. 706 
 707 
Figure 5: DUSP10 knock down does not affect the response of PBECs to RV infection. PBECs 708 
were untransfected or treated with DUSP10 (D10) or control (Ctrl) siRNA (100 nM) for 48 h. 709 
Cell lysates and supernatants were collected and analysed for DUSP10 expression by qRT-PCR 710 
(A) and western blot (B). PBECs were then infected with RV1B (MOI 3), RV16 (MOI 4), or 711 
poly(I:C) (25 μg/ml). Cell lysates and supernatants were collected after 24 h and analysed by 712 
ELISA for CXCL8 (C) and CCL5 (E) or after 16 h and qRT-PCR performed for IFN-β (D). RV RNA 713 
levels after 24 h were measured using qRT-PCR (F). Data shown are mean ± SEM, n=3 714 
individual donors, except F n=4 individual donors. Significance between siRNA treatments is 715 
indicated by * p ≤ 0.05 as measured using one-way ANOVA Dunnett’s post-test on log ΔCt 716 
values (A) or log protein expression (B) or two-way ANOVA, Sidak’s post-test on log data (C-717 
F). 718 
 719 
Figure 6: DUSP10 knock down increases cytokine production but not MAPK activation in 720 
response to IL-1β. PBECs were treated with DUSP10 (D10) or control (Ctrl) siRNA (100 nM) 721 
for 48 h prior to stimulation with IL-1β (1-100 ng/ml) for 24 h. Cell lysates and supernatants 722 
were collected and CXCL8 measured by qRT-PCR (A) and ELISA (B), n=4 individual donors. 723 
PBECs were treated with siRNA for 48 h prior to stimulation with IL-1β (100 ng/ml) for 30 724 
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minutes. Cell lysates were collected and levels of phosphorylated p38 and JNK and total actin 725 
were measured using western blot. Data shown are mean ± SEM of band density with 726 
representative blots shown, n=3 individual donors (C). Significance between siRNA 727 
treatments is indicated by * p ≤ 0.05 as measured by two-way ANOVA, Sidak's post-test on 728 
log data. 729 
 730 
Figure 7: The effect of DUSP10 knock down on cytokine expression in response to IL-1β. 731 
PBECs were treated with DUSP10 (D10) or control (Ctrl) siRNA (100 nM) for 48 h prior to 732 
stimulation with IL-1β (10 ng/ml) for 24 h. Supernatants were collected and cytokine array 733 
performed. Data presented are spot density normalised to cell number, n=1. 734 
 735 
Figure 8: IL-1β is released in response to RV infection. PBECs were infected with RV1B (MOI 736 
3) or RV16 (MOI 4) for 24 h. Supernatants were collected and levels of IL-1β release were 737 
measured by ELISA. Data shown are mean ± SEM, n=3 individual donors. Significance versus 738 
uninfected cells is indicated by * p ≤ 0.05, *** p ≤ 0.001, as measured by one-way ANOVA, 739 
Dunnett’s post-test on log data. 740 
 741 
Figure 9: IL-1β potentiates the response of PBECs to RV infection. PBECs were treated with 742 
control (Ctrl) or DUSP10 (D10) siRNA (100 nM) for 48 h prior to stimulation with IL-1β (1 or 10 743 
ng/ml) and/or infection with RV16 (MOI 4) (A and B), RV1B (MOI 3) (C) or RV14 (D) for 24 h. 744 
Cell supernatants and lysates were collected and CXCL8 measured by qRT-PCR (A) and ELISA 745 
(B, C, D). Significance is indicated by * p ≤ 0.05, ** p ≤ 0.01 *** p ≤ 0.001, **** p ≤ 0.0001 746 
between Ctrl and D10 siRNA as measured by two-way ANOVA Sidak's post test, or # between 747 
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RV alone and in combination with IL-1β as measured by two-way ANOVA Dunnett’s post-test 748 
on log raw data, n=3 individual donors. 749 
 750 
Figure 10: DUSP10 expression is decreased by RV infection in COPD cells and DUSP10 knock 751 
down increases CXCL8 release. COPD PBECs were infected with RV1B (MOI 3), RV16 (MOI 4), 752 
or IL-1β (100 ng/ml) over 24 h and cell lysates collected at the indicated time points. DUSP10 753 
expression was measured using qRT-PCR (A) and western blot (B). Data shown are mean ± 754 
SEM n=3 individual donors. Densitometry is shown in B with a representative blot in C. 755 
Significance was measured by one-way ANOVA, Dunnett's post-test on log ΔCt values (A) or 756 
log densitometric values (B). COPD PBECs were treated with control (Ctrl) or DUSP10 (D10) 757 
siRNA (100 nM) for 48 h prior to stimulation with IL-1β (1 or 10 ng/ml) and/or infection with 758 
RV16 (MOI 4) for 24 h. Cell supernatants were collected and CXCL8 measured by ELISA, n=2 759 
individual donors (D). 760 
 761 
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